Thiazole compounds useful as inhibitors of protein kinase
CA 2446756 C · Owner: Nanthakumar, Suganthini · Inventors: Wang, Jian; Harrington, Edmund; Nanthakumar, Suganthini
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a compound of formula I: or a pharmaceutically acceptable derivative thereof. These compounds are inhibitors of protein kinases, particularly inhibitors of GSK3 Aurora2, and Syk mammalian protein , kinases. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatement of various protein kinase mediated disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 23, 2002 and granted March 8, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 23, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 23, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.